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Abstract
PURPOSE—Extending previous Canadian-United States cancer survival comparisons in large
metropolitan areas, this study compares breast cancer survival in smaller metropolitan areas:
Winnipeg, Manitoba and Des Moines, Iowa.
METHODS—Manitoba and Iowa cancer registries, respectively, provided a total of 2,383 and
1,545 women with breast cancer (1984 to 1992, followed until December 31, 1997).
Socioeconomic data for each person’s residence at the time of diagnosis was taken from
population censuses.
RESULTS—Socioeconomic status and breast cancer survival were directly associated in the US
cohort, but not in the Canadian cohort. Compared with similar patients in Des Moines, residents of
the lowest fifth of income areas in Winnipeg experienced a significant 5-year survival advantage
(survival rate ratio [SRR] =1.14). In these lowest income areas, the Canadian survival advantage
was larger among women aged 25 to 64 years (SRR = 1.23), and this was observed in the middle
fifth of income areas among this younger cohort (SRR = 1.11). The Canadian survival advantage
even seemed apparent in the poorest neighborhoods with relatively high representations of
Aboriginal people (SRR = 1.16).
CONCLUSION—This study replicated the finding of advantaged Canadian cancer survival in
smaller metropolitan areas that had been consistently observed in larger metropolitan areas.
Canada’s single payer health care system seems to offer similar advantages across a number of
diverse urban contexts.
Keywords
Cancer; Survival; Socioeconomic Factors; Health Insurance; Canada; United States; Urban
Population; Cohort Study; Epidemiologic Study; Effect Modifier
INTRODUCTION
The past decade has seen significant changes in the way health care is financed and
delivered in both Canada and the US. During this era of shifts to more conservative North
American governments, heated political debates about health care and other welfare state
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program reforms have tended to focus on their costs. For example, while health care in the
US largely shifted to management by for-profit health maintenance organizations, Canada
aimed for greater health care efficiency by shifting fiscal responsibility from the federal
government to the provinces. The obvious importance of health care costs notwithstanding,
rational policy decisions probably cannot be made without similarly accepting the
importance of the other side of cost-benefit equation benefits. Indeed, the observation of
relatively beneficial or detrimental health care outcomes can provide empirical sentinels for
the informing of policy decisions by epidemiologic and allied sciences.
Cancer survival is one such sentinel health care outcome. Because diverse types of cancers
are, in aggregate, relatively common over the life course, and early diagnosis and access to
the best available treatments can result in relatively good prognoses with a high quality of
life among the majority of patients. Cancer survival is one good indicator of a health care
system’s effectiveness. Recent comparisons between Canada, with universal access to
necessary medical health care, and the US, with a multitiered health care system in which
insurance inadequacy is a prevalent problem, have been instructive in this regard (1). These
international comparisons have consistently observed significantly shorter survival among
those of lower socioeconomic status (SES) for nearly all of the most common types of
cancer in the US, while a consistent pattern of no association between SES and survival has
been observed in Canada (2–5). As for the critical between-country comparisons, consistent
Canadian survival advantages have been observed for nearly all of the most common types
of cancer among the residents of the lowest income areas and also among the residents of
some lower middle-class and working-class neighborhoods. Moreover, the observed
Canadian advantages have been largest among patients less than 65 years of age. The
consistent pattern of findings of this series of retrospective cohorts arising from diverse
contexts (Toronto, ON; Detroit, MI; San Francisco, CA; Seattle, WA; Hartford, CT; and
Honolulu, HI) seems to point compellingly toward the different health care systems in
Canada and the US as its most cogent explanation.
So far, this research’s inferences are most legitimately generalized to large metropolitan
areas with populations of one to four million people. Large metropolitan samples were
originally selected because they probably offer substantial control for health care service
endowments. In both Canada and the US, primary care, as well as specialized cancer care
services (oncologists, surgeons, investigative [e.g., laboratory] and therapeutic [e.g.,
radiation therapy facilities]), are readily available in such areas. Critical between-country
comparisons then tested their relative accessibility. We think that Toronto, Ontario was a
good place to start examining the Canadian situation. Because one out of every seven
Canadian residents lives in Toronto, its use probably provided a significant external validity
benefit. Still, as an alternative to the health insurance hypothesis, it could be conjectured that
Toronto’s large health care service endowment is so unrepresentative of the rest of Canada
that the cancer survival advantages observed among the residents of its relatively low
income areas as compared with similarly poor Americans may not be replicable in other
Canadian locales. The present analysis tests this alternative hypothesis by means of a
systematic replication of previous Canada-US cancer survival comparisons with samples
from two smaller cities with populations ranging from one half to three-quarters of a million
people: Winnipeg, Manitoba, and Des Moines, Iowa.
This analysis focuses on a type of cancer that is perhaps of greatest public health
significance in North America breast cancer. In addition to being the most common cancer
among North American women, breast cancer fits the above outlined exemplar of a good
health care indicator very well: early diagnosis and access to the best available treatments
are predictive of good prognoses with a high quality of survivable life. Moreover, breast
cancer survival outcomes have consistently fit the pattern of a Canadian survival advantage
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across all of our Canada—US comparisons in relatively low-income areas. Also of note,
other US analyses have found social factors such as SES, race and ethnicity to be rather
strongly associated with breast cancer screening practices, prognostic factors such as the
stage of disease at the time of diagnosis, as well as access to the best available treatment (6–
15). Among Canadian samples, however, such associations have been found either non-
significant or much smaller. (16–20). The pattern of American associations is consistent
with the health insurance hypothesis because various low SES or underclass groups
including people of color are known to be at much greater risk than others of being
uninsured or under-insured. Such inadequate health insurance statuses are highly associated
with the nonreceipt of primary care, cancer screening services and various cancer treatments
across a variety of US contexts (1,21–25). We therefore hypothesized that, similar to
Canadian survival advantages observed in larger metropolitan areas, relatively poor breast
cancer patients in Winnipeg, Manitoba would survive longer than their similarly poor
counterparts in Des Moines, Iowa.
METHODS
Study participants were residents of metropolitan Winnipeg, Manitoba (population of
650,000 in 1991) and Des Moines, Iowa (400,000 in 1990) (26–28) The data sources were
the Manitoba Cancer Registry and the US Surveillance Epidemiology and End Results
(SEER) program. Definitions of the study cohorts were constrained by power calculations
and the date of last follow-up of the US cohort: December 31, 1997 (29,30). A 5-year
survival analysis was based on cumulative incident first primary breast cancer cases
diagnosed from 1984 to 1992. Power calculations based on the between-country breast
cancer survival comparisons reported in previous studies as well as the following criteria
(power [1 − β] = 0.80, α = 0.05), (2–5,31) determined that there would be sufficient power
to detect a survival rate ratio (SRR) of 1.10 among all of the patients and a SRR of 1.20
among the smaller sample of patients aged 25 to 64 years. All first primary malignant
cancers of the breast among adult women (25 or older) were included in the analysis: 2383
women in Winnipeg and 1545 women in Des Moines.
As did our previous studies, the present analysis used a census-based SES measure (census
tract proportion meeting a “low income” criterion in Canada and “poverty” threshold in the
US) to define relative income quantiles. These, respective, Statistics Canada and US Bureau
of the Census, indices of economic impoverishment or deprivation are conceptually similar.
Both of them are based on annual household income from all sources, adjusted for
household size, and tied to the consumer price index. The Canadian low-income cutoff is a
more liberal criterion though, approximately equal in 1990 to 1991 to 200% of the US
poverty threshold (32). The analytic goal for the use of such census-based socioeconomic
measures was the aggregation of people with cancer into relative quintiles, that is, low- to
high-income areas within countries. Geographic coding was based on each person’s
residence at the time of diagnosis: coded as postal codes (converted to census tracts) (33) in
the Manitoba data set and as census tracts in the SEER data set. The statistical power criteria
noted above allowed for comparison between corresponding Winnipeg and Des Moines
income area quintiles. The relative quintile ranking of US census tracts was observed to be
nearly identical whether 100%, 150% or 200% poverty threshold criteria were used. We
therefore chose to use the most straightforward and prevalent one—the standard (100%)
poverty threshold. Other issues of predictive and face validity, also supported our selection
of the arguably, simplest, and most straightforward income-based socioeconomic measures
(34–40). Across developed nations including Canada and the US, when socioeconomic-
health associations exist, income has repeatedly been observed to be highly associated with
various morbid and mortal outcomes than education or occupation (41–44). The
unidimensional constructs of relatively “low income” or “poverty” areas, vs. more abstract
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mulifactorial statistical constructions that may, for example, simultaneously model five or
more socioeconomic dimensions, are easily identifiable and well understood, not only by
scholars, but by most residents of North America’s cities (45).
Descriptive profiles of the resultant income areas that are displayed in Table 1, demonstrate
two important points: (i) the construct validity of this study’s ecological measures of relative
SES are supported by the clear median income hierarchies observed in both Winnipeg and
Des Moines; and (ii) even though statistics of Canada’s low income criterion is much more
liberal than the US Census Bureau’s poverty threshold, the corresponding Winnipeg-Des
Moines relative income areas are strikingly similar in terms of typical incomes. In fact, the
relatively small absolute income differences that do exist probably serve to make this
study’s hypothesis test a conservative one. For example, in the lowest income quintile areas,
households in Des Moines had an average annual income advantage of $2000, but their
counterparts in Winnipeg are still hypothesized to have a cancer survival advantage.
Moreover, the local patterns of income differentials among this study’s samples seem
distinctly different from the well-known national ones where the differences between the
rich and the poor are larger in the US. Within this study’s analytic context (aggregate
relative socioeconomic areal fifths in Winnipeg, 1991 and Des Moines, 1990 [median
household income]), the difference between the highest and lowest quintiles was actually
larger, nearly 20% larger, in the Canadian sample. This pattern seems to lend further
credence to the notion that this study’s Canada-US comparison on breast cancer survival is
probably a rather conservative one.
This study’s specific metropolitan data sets were nearly identical on data quality indicators.
In both cases, more than 96% of their residences (census tracts) at the time of diagnosis were
coded; those missing residential data were censored at the time of diagnosis. More than 96%
of their breast cancers were microscopically confirmed and less than 0.5% of them were
enumerated on the basis of death certificates only. While it is true that between-country case
ascertainment differences do exist, particularly with regard to the registration of second
primaries (involving the same histologic site, e.g., right and left breast [less than 5% of all
breast cancer patients]) (46–49). Such methodological differences probably cannot confound
this study analysis as it was restricted to first primaries. This analytic plan, therefore, puts
the emphasis on patient’s first point of entry into the, respective, Canadian or American
cancer care systems.
Observed survival rates were directly age-adjusted using this study’s combined Winnipeg-
Des Moines population of breast cancer patients across the following age strata: 25 to 44, 45
to 54, 55 to 64, 65 to 74, and 75 years of age or older (50). Relative survival rates based on
life table methods were not calculable across this study’s unique Canadian and US
socioeconomic quintiles as the age and time-dependence of competing risks in such areas
are unknown. Among all of the women with breast cancer who were dead at five-year
follow-up, 81% died as a direct result of cancer, while among the sample of patients
diagnosed before age 65, nearly all subsequent deaths were attributable to their cancer
(93%). Survival comparisons across specific income area strata were then accomplished so
that survival rate ratios (SRRs) were greater than 1.00 if Winnipeg residents were
advantaged. Ninety-five percent confidence intervals around SRRs were based on the
Mantel-Haenszel chi-square test (50,51). And survival trends across income quintiles were
tested (α criterion of 0.05) by means of the Mantel extension procedure (52,53).
RESULTS
First, concerning within-country analyses, it was observed that the Winnipeg breast cancer
cohort demonstrated no association between SES and survival, while the Des Moines cohort
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did (Table 2). As compared with Des Moines’ highest income area, five-year survival rates
were significantly lower in Des Moines’ middle and lowest income areas (SRRs of 0.90 and
0.79, respectively), representing a statistically significant trend that is probably due to the
relatively low survival rate in the lowest quintile. As hypothesized, the two country’s
aggregate breast cancer patient cohorts did not differ significantly on survival in any but the
lowest income areas. Among these relatively lowest income groups, a significantly higher
survival rate was observed in Winnipeg (SRR = 1.14). Finally and more specifically, in
these lowest income areas, the Winnipeg survival advantage was greater among women
aged 25 to 64 (SRR =1.23), and it was also observed in the middle fifth of income areas
among this younger cohort (SRR = 1.11).
Adjunct Exploratory Analysis
Nearly all of Des Moines’ residents are white (94%), but less than two-thirds of Winnipeg’s
residents have been so categorized by recent censuses, and one of its most prevalent
minorities are Aboriginal people (26–28). The Manitoba Cancer Registry does not code race
or ethnicity. Selection of a Winnipeg low-income area with relatively high Aboriginal
representation allowed for another, probable conservative, test of the health insurance
hypothesis (i.e., the Canadian sample for this analysis probably had much greater Aboriginal
representation than the American one). Nineteen census tracts comprised of 15% or more
Aboriginals that were all among Winnipeg’s lowest socio-economic quintile (median
Aboriginal prevalence of 24%, median low income prevalence of 53%, and median
household income of $15,150) were substituted for the original 31-tract low-income area
quintile. Replication of the original analyses with this Aboriginal-concentrated low-income
area found that the SES-breast cancer survival nonassociation in Winnipeg remained as did
the survival advantages enjoyed by relatively poor “Winnipegers” (e.g., patients aged 25 to
64, Winnipeg vs Des Moines’ lowest income quintile; SRR = 1.16 [95% CI; 0.98, 1.38 and
90% CI; 1.01, 1.34]).
DISCUSSION
This study demonstrates the breast cancer survival advantage of Canadians relative to
Americans in smaller metropolitan areas that previously had been consistently observed in
larger metropolitan areas. Significant, though distinctly nonmonotonic, SES-breast cancer
survival gradients were observed in the US cohort, but not in the Canadian one. The impact
of these different within-country SES-survival associations were specifically observed in
relatively poorer areas where there are higher residential concentrations of such categorical
groups as the poor, the so-called near poor, including the working poor, as well as better-off
working people, even including members of the middle-class, who, for a number of social
structural and economic reasons, are periodically or chronically uninsured or underinsured
in the US. These are the kinds of impoverished to middle income areas where the cancer
survival advantages enjoyed by Canadian patients seem to be most apparent. Furthermore,
such Canadian advantage seems to be greater among younger women (not yet entitled to
Medicare coverage in the US), and to be maintained even in the poorest neighborhoods with
relatively high representations of Aboriginal people. This study’s pattern of findings further
substantiates the health insurance hypothesis as an explanation for Canadian-US differences
in cancer survival in diverse urban contexts. Its findings are consistent with estimates that
more than a third of all breast cancer patients in the US do not receive the minimum
expected best available treatments (9,54,55). And more generally, this study’s findings are
consistent with the recently observed strong associations of income inequality with health
care access (failure to receive needed care, difficulty getting care), affordability (problems
paying medical bills, failure to fill prescriptions due to cost) and mortal outcomes in the US,
but not in Canada (56,57). One clear effect of Canada’s comprehensive social policies, of
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which universal access to health care seems most cogent, is that the quality of health care
received seems generally not to be related to the ability to pay for it. Most citizens would
probably agree that this should be one central goal of any health care system.
Having found further suggestive evidence of the equitable access and quality of health care
enjoyed by urban Canadians, it ought to be noted that Canada is not without health care and
social inequities. For example, though Aboriginal status was apparently not associated with
the quality of cancer care in this study’s Winnipeg sample, Aboriginal status was very
strongly associated with low income status. As for health care, significant variabilities in
access and outcomes have been observed within various provinces (16,58–64) but such
gradients seem more probably to be a function of different regional health care service
endowments, rather than of personal income or other SES-related differences. For example,
primary care as well as specialized health care services is obviously far less available in the
furthest outlying northern rural expanses of many provinces. Policies to effectively diminish
health care inequities in such regions will necessarily be quite different from those needed to
effect similar change in US metropolitan areas. Better knowledge is needed though to
effectively steer such policy decision on both sides of the border. Future research that
integrates the knowledge of physicians, epidemiologists, human geographers, allied
scientists and policy makers will not only be better able to extend this field’s internal and
external validity, but also to produce practical knowledge capable of steering health care
policies in Canada and the United States.
Possible Alternative Explanations
Our assertion that a relative lack of health insurance and a consequent lack of access to
health care services among relatively poor American cancer patients is the most plausible
explanation for the rather consistent pattern of Canadian survival advantages observed in
this and other studies was based on three empirically grounded assumptions: (i) more than
half of the residents of Des Moines’ lowest areal income fifth were poor or “near poor” (up
to 200% of the federally established poverty criterion); (ii) various relatively low
socioeconomic and underclass statuses are known to be strongly associated with being
uninsured or underinsured in the US; and (iii) such associations cannot possibly exist in
Canada, as insurance status pertinent to necessary medical care is not even a variable, but
rather a constant—every resident is so ensured under Canada’s Medicare Act (1,2–5,28).
Therefore, this study’s income-based critical comparison groups—cancer patients who
resided at the time of their diagnosis in the relatively lowest fifth of income areas in
Winnipeg, Manitoba and Des Moines, Iowa—probably served as close respective proxies
for well-ensured vs. relatively inadequately ensured groups. By definition then, a factor that
could represent a similar or more plausible alternative or confounding explanation would,
we think, have to minimally meet the following three criteria: (i) be strongly associated with
socioeconomic or insurance status in the US, but not with SES in Canada; (ii) differ
significantly between Canada and the US, particularly among their respective poorest
people; and (iii) be an independent moderate or stronger risk or protective factor for cancer
survival. For these reasons we think that, while any number of other behavioral or cultural
factors, for example, are probably integral to a thorough understanding of health care
outcomes, it is unlikely that any of them can rival the potent ability of health insurance to
explain the observed Canadian-American cancer survival differentials.
One such possible alternative explanation for this study’s findings that could be advanced
concerns the actual income differentials in the US and Canada. The economic divide
between relatively rich and poor Americans is large and growing, and it is well known to be
larger than the Canadian divide (65,66). Therefore, the greater marginalization of some
relatively poor Americans could possibly contribute to their cancer survival disadvantage,
over and above their lack of access to the best available health care. Two arguments
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essentially rule out this demographic pattern as a potent confounding explanation. First, as
noted in this study’s methods sections, not only were this study’s Canadian and American
samples not representative of the typically noted cross-national differential (American
greater than Canadian economic inequality), but they, in fact, demonstrated a slight
between-country difference in the opposite direction (Canadian [Winnipeg, Manitoba]
greater than American [Des Moines, Iowa] economic inequality [confounding criteria #2 not
met, between-country difference was counter-hypothetical]). Among this study’s sample,
although economic marginalization was likely be greater among the relatively poor
Canadian subsample, they still enjoyed a significant survival advantage compared with their
American counterparts. Within this particular study sample’s context then, the findings
certainly seem most consistent with systemic, rather than with personal or cultural
explanations. Second, while it is true that studies of income inequality and mortality among
developed nations have observed attenuated Canadian vs. American associations (56,67–
69). Because they have all focused on mortality, which is a function of both incidence and
survival, their designs leave the myriad possible causes of disease occurrence and survival
confounded (70). None of this field’s studies have focused on survival, per se, and most of
the purported inequality correlates (e.g., life style factors, stress) that are the primary
hypothesized causes of mortality, have been consistently empirically linked with the
occurrences of various diseases including cancer, but not necessarily with their survival. We
are unaware of any studies that have demonstrated an independent link between such
measures of economic inequality and cancer survival in Canada, the US or elsewhere
(confounding criteria #3 not met). Therefore, though income inequality most assuredly has
very important worldwide public health implications, particularly with respect to the
incident causes of disease (e.g., tumor initiation and progression), it probably does not
provide a plausible alternative explanation for this study’s cancer survival-based findings.
Life style factors such as diet, physical activity, body mass, smoking and alcohol
consumption, that were alluded to above, are another constellation of factors that would
certainly seem to warrant consideration as possible alternative explanations for this study’s
central findings. However, upon closer examination, we think that it is quite clear that life
style factors, in aggregate, do not meet any of the three confounding definitional criteria: (i)
various SES-life style factor associations are well known to exist in both the US and
Canada, not merely in the US; (ii) though we are unaware of any studies that have
specifically compared the low income areas of Winnipeg and Des Moines on these factors,
prevalence studies of general Canadian and US populations contemporary with this one’s
data collection phase have found very small prevalent differences on life style-related
factors, typically on the order of magnitude of only plus or minus 2%; and (iii) life style
factors that have been observed to be strongly associated with cancer occurrence, only seem
to be weakly associated with cancer survival, if at all (71–74,75–82). Again, though of
obvious public health significance in both Canada and the US, particularly with respect to
the occurrence of cancer as well as other prevalent morbid outcomes, extant knowledge of
life style factors does not seem at all consistent with this study’s observed Canadian cancer
survival advantage among the relatively poor. Therefore, we do not think that such factors
even minimally confound the hypothesized health insurance-survival relationship.
Cultural hypotheses related to various differences between social classes or ethnic groups on
cancer preventive behaviors and rates of cancer screening participation have been
developed, but remain largely untested. Actually though, the few studies that do exist seem
to suggest that it is knowledge and relatedly, the level of achieved education, rather than any
culture-specific minority group attitude or belief differences which may account for much of
the observed differences on cancer screening (83–88). This phenomenon probably accounts
for at least some of the cancer survival disadvantage among relatively poor Americans, and
as such is closely aligned with the health insurance hypothesis. It tends to indict America’s
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inequitable distribution of essential social resources—education and health care. As for the
specific ethnic groups that this study indirectly compared—Native or Aboriginal people of
Canada and the US—similar socioeconomic and related disadvantages (e.g., rural vs urban,
reserve vs off-reserve residence), particularly with respect to the occurrence of various
diseases including cancer, have been observed among both Canadian and American
Aboriginals as compared with their respective within-country white counterparts (89–93).
Thus, ethnic and related cultural factors do not seem to meet any of the three definitional
confounding criteria. Unfortunately, various ethnic minority groups, including Aboriginal
people in Canada and the United States, still experience multiple systemic disadvantages.
Though this is an issue of profound public health and social policy significance, it does not
seem to provide a convincing alternative explanation for this study’s observed, Aboriginal-
specific, Canadian cancer-survival advantage.
Finally, this study was methodologically limited and potentially confounded by its inability
to accomplish stage-specific analyses (the Manitoba Cancer Registry did not routinely
include breast cancer stage during this study’s incident time frame). SES-specific cancer
stage compositional differences might be hypothesized, for example, to account for the
observed between-country differences in survival. We agree that they probably do account
for some, but not all of the differential. The only stage-stratified study that we are aware of
in this field found a 5% survival advantage among Ontario patients with localized glottic
cancer as compared with similarly staged American patients (94). However, this study did
not account for SES. Our health insurance theory leads to the prediction that the Canadian
stage-adjusted survival advantage would be even larger among, respective, low-income
Canadian and American strata. This and related hypotheses await future testing. Our own as
well as other within-US analyses have found that cancer stage and treatment differences are
both strongly associated with health insurance status and survival, each accounting for
approximately half of the criterion survival variability (1,41,95). Moreover, in the US cancer
stage at the time of diagnosis is itself probably largely determined by multiple systemic,
health-insurance mediated factors: a lack of pre-symptomatic primary care, post-
symptomatic delays to primary care, even so-called personal delays, related to not having a
usual source of care or having experienced a lack of primary care continuity, and delays to
cancer care (diagnosis and treatment) that may be related to a lack of effective screening,
investigation, oncology referral, other referrals such as surgery, or follow-up advocacy (96–
101). Between-country outcome comparisons notwithstanding, it is acknowledged that we
yet have much to learn about respective within-country health care processes, pre- and post-
diagnosis, in both Canada and the US. In response, it is our ongoing intention to plan and
carry out ever more complex and coherent international population health and health
systems analyses. Our own research group as well as a number of others of which we are
aware, for example, are planning to add stage and treatment variables to various samples of
Canadian provincial cancer registries. Such enhanced databases will ultimately allow for
more coherent within- (e.g., pre-post health care policy changes) and between-country
comparisons of the processes and outcomes of cancer care in Canada and the US.
CONCLUSION
This study replicated the finding of advantaged Canadian cancer survival in smaller
Canadian and American metropolitan areas that had been consistently observed in larger
such metropolitan areas. During this study cohort’s retrospective time frame the—mid 1980s
to the mid 1990s—more inclusive health care insurance coverage in Canada vs. America,
particularly among each country’s respective relatively poor people, seems the most
plausible explanation for such Canadian survival advantages. Canada’s single payer health
care system seems to have offered similar advantages across a number of diverse urban
contexts. Such historical findings may serve as sentinel cautions against future policies that
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would transform Canada’s single payer health care system into a multitiered one and as
concomitant policy incentives to provide all Americans with health insurance.
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al
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R
R
 =
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al
 ra
te
 ra
tio
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I =
 c
on
fid
en
ce
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te
rv
al
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at
a 
fo
r w
om
en
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ge
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65
 a
nd
 o
ve
r a
re
 n
ot
 sh
ow
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se
pa
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te
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 b
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r w
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 c
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gn
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ca
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an
65
 y
ea
rs
 o
f a
ge
 [p
 =
 .0
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al
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b C
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fid
en
ce
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 o
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th
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l c
hi
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ar
ed
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